Narodna in univerzitetna knjižnica, Ljubljana (NUK)
Naročanje gradiva za izposojo na dom
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi
  • Učinek podvezničnega bevacizumaba na pterigij = Efficiency of subconjunctival bevacizumab on pterygium
    Lavrič, Alenka, oftamologija ; Drnovšek-Olup, Brigita
    Background: To evaluate the effect and complications of subconjunctival bevacizumab (Avastin Ž) on primary and recurrent pterygium. Methods: This prospective study included sixteen patients with ... pterygium, who received subconjunctival injection of bevacizumab (1.25 mg/0,1 mL). Digital photographywas used to evaluate vascularization of pterygium at 1 week, 1 month and 6 months after injection. Results: Sixteen patients (9 men and 7 women), aged between 41 and 74 years, with pterygium were included in the study. The pterygium was primary in nine patients and recurrent in seven patients. A rapid regression of vascularisation of pterygium was noted one week after treatment in all patients treated with bevacizumab. The recurrence was observed in two patients 1 month and in ten patients 6 months after injection. No change of visual acuity was noted and no systemic or ocular adverse events were observed. Conclusions: Subconjunctival bevacizumab (AvastinŽ) was safe and effective in providing a short-term regression of conjunctival vessels in the pterygial bed.
    Vrsta gradiva - članek, sestavni del ; neleposlovje za odrasle
    Leto - 2012
    Jezik - slovenski
    COBISS.SI-ID - 294316